Protein may be treatment target in advanced PCa

Vancouver, British Columbia - Clusterin, a stress-related protein, appears to inhibit apoptosis associated with androgen withdrawal and may therefore be an important therapeutic target in men with advanced prostate cancer, say researchers from the University of British Columbia.